Bloomberg: CVS-Aetna deal close to clearing antitrust process
CVS Health’s takeover of health insurance giant is likely close to clearing the antitrust process with the Department of Justice, Bloomberg reported last week.
The deal, which is valued at approximately $69 billion, has come under fire recently over concerns of declining market competition and consumer choice.
CVS officials were confident the deal would move forward during the company’s most recent quarterly earnings call with analysts, and even specified when they expect the transaction to close–a sign that the deal will win approval of federal regulators, according to Bloomberg.
Read the full story below:
Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."